查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1931254

整形外科植入用镁合金市场：植入类型、材料等级、应用和最终用户划分，全球预测（2026-2032年）

Magnesium Alloy for Orthopedic Implants Market by Implant Type, Material Grade, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年，用于整形外科植入的镁合金市场价值为2.3415亿美元，预计到2026年将成长至2.5294亿美元，复合年增长率为8.27%，到2032年将达到4.0856亿美元。

关键市场统计数据
基准年 2025 2.3415亿美元
预计年份：2026年 2.5294亿美元
预测年份 2032 4.0856亿美元
复合年增长率 (%) 8.27%

本文全面概述了合金化学、表面工程和临床证据的进展如何重塑镁植入在现代整形外科护理中的应用。

镁合金因其优异的机械性质、生物降解性和与骨癒合生理的相容性，已成为整形外科植入的主要材料之一。合金化学和表面工程的最新进展提高了腐蚀控制能力，使设计人员能够充分利用其独特的强度和渐进式吸收特性，这种特性与骨重塑的生物学时间线相吻合。在某些适应症中，这项特性减少了二次取出手术的必要性，为仅需临时结构支撑的新型治疗模式开闢了道路。

来自临床医生、监管机构和医疗保健系统的共同需求正在加速镁基整形外科器材的材料创新和临床应用。

随着材料创新、临床需求和医疗保健系统经济的融合，整形外科领域正经历着变革性的转变。其中显着的变化包括临床上越来越重视减轻植入的长期负担。外科医生和患者都在寻求能够在癒合期间提供足够机械支撑并在癒合后被安全吸收的解决方案，从而避免再次进行植入物取出手术。这种临床需求推动了镁合金研究从实验室到器械原型再到早期临床应用的进程，而腐蚀控制技术的不断进步正在缓解先前对镁合金快速劣化的担忧。

评估近期关税政策变化如何重塑镁植入价值链的供应链策略、垂直整合和采购决策。

美国近期关税政策的变化为镁合金植入物製造商和经销商的供应链带来了新的变数。关税调整将影响进口原料、半成品和成品的成本结构，进而影响筹资策略和製造地地点。许多供应商正在积极应对，评估替代采购管道，尽可能提高国内加工能力，并协商签订长期合约以规避价格波动风险。

基于全面细分的洞察，植入几何形状、临床应用、通路和材料等级与商业化要求相匹配。

了解产品和临床细分的细微差别对于优先开发和推出镁合金植入至关重要。植入类型包括钉、板、棒和钉以及螺丝。板又可细分为加压板、锁定板和重组板；棒和钉包括髓内钉和锁定棒；螺丝则分为鬆质骨螺丝、皮质骨螺丝和自攻螺丝。每种植入几何形状都对机械性能和劣化性能有独特的要求，这些要求会影响合金的选择、热处理通讯协定和表面处理技术。

区域监管差异、临床医生采纳模式和生产能力将如何影响关键全球区域的商业化策略

区域趋势将影响镁合金植入的监管预期、临床应用模式和供应链策略。在美洲，临床医生和医院系统越来越乐于接受能够减轻长期手术负担的创新技术，但这些技术需要可靠的临床证据和清晰的监管文件。此外，该地区集中采购集团和一体化医疗保健系统能够加速那些展现出明显临床和经济优势的产品的推广应用。

一体化合金研发、卓越製造和临床伙伴关係是市场领导和细分领域专家的标誌。策略竞争概览。

镁植入领域的竞争格局呈现出多元化的态势：既有老牌整形外科器械製造商向生物可吸收金属领域拓展，也有专注于合金创新和表面处理技术的材料及组件开发商。领先企业正透过其在合金开发、精密製造和临床合作方面的综合能力来加速实证医学的产生，从而实现差异化竞争优势。一些公司强调专有的表面涂层和腐蚀控制技术，以实现临床上可预测的降解曲线；而其他公司则专注于製程控制和认证，以支援大规模生产。

镁植入製造商可采取的策略重点，以协调临床证据、供应链韧性和针对性的商业化工作

行业领导者应采取多管齐下的策略，将材料的潜力转化为临床和商业性的成功。首先，应优先进行有针对性的临床研究，使植入设计、材料等级选择和手术技术与外科医生和支付方真正关心的实际终点指标一致。能够捕捉功能性结果和再次手术率的实用性试验和註册研究尤其重要。其次，应投资加强供应链韧性，具体措施包括：实现关键原材料供应商多元化、认证区域製造合作伙伴以及实施合约保障措施，以降低关税和物流风险。

该研究详细描述了调查方法，该方法整合了临床医生访谈、材料科学文献、监管指南和供应链分析，以得出经过检验的评估。

本分析背后的研究综合了多种资讯来源，旨在对镁合金在整形外科植入中的应用进行评估，从而形成一个平衡且基于证据的观点。主要研究包括：对创伤外科医生、脊椎外科医生和颅颚颜面医生进行结构化访谈；与材料科学家、法规顾问和医疗设备製造商进行对话；以及与供应链和分销相关人员进行直接磋商，以了解采购趋势。这些定性资讯与已发表的科学文献、法规指导文件和临床试验报告进行交叉比对，以检验材料性能声明和临床终点。

本文简要总结了材料技术进步、临床完整性和商业化需求，这些因素共同定义了负责任地采用镁基整形外科植入。

总之，镁合金是整形外科应用中具有战略意义的重要材料，其临时机械支撑和良好的生物吸收性能符合临床目标。合金成分、表面处理和製造技术的进步克服了许多历史限制，从而实现了更可预测的劣化曲线和更高的机械可靠性。同时，不断发展的临床实践和明确的监管政策正在为负责任的应用铺平道路，前提是研发人员投资于实证实践和供应链的稳健性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章整形外科植入用镁合金市场（依植入类型划分）

  • 别针
  • 盘子
    • 压缩板
    • 锁板
    • 重组板
  • 桿和钉子
    • 髓内钉
    • 锁桿
  • 拧紧
    • 鬆质骨螺丝
    • 皮质螺丝
    • 自攻螺丝

第九章 依材质等级分類的整形外科植入用镁合金市场

  • AZ31
  • Mg-Ca
  • Mg-Zn
  • WE43

第十章 依应用领域分類的整形外科植入用镁合金市场

  • 颅颚颜面外科
  • 牙科
  • 脊椎
    • 微创手术
    • 开放性手术
  • 运动医学
  • 创伤
    • 肢体创伤
    • 骨盆创伤

第十一章整形外科植入用镁合金市场（以最终用户划分）

  • 门诊手术中心
  • 医院
  • 专科诊所

第十二章 各地区整形外科植入用镁合金市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章整形外科植入用镁合金市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国整形外科植入用镁合金市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国镁合金整形外科植入市场

第十六章 中国整形外科植入用镁合金市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Alloy OrthoTech Co., Ltd.
  • Bioretec Oy
  • Biotronik SE & Co. KG
  • Bone Solutions Ltd.
  • Dongguan Eontec Co., Ltd.
  • Magmaris Ltd.
  • Magnesis Biomedical GmbH
  • Magnesium Bioabsorbables Pvt. Ltd.
  • Magnesium Development Company Ltd.
  • Magnesium Innovations Inc.
  • MedAlloy Technologies Inc.
  • Medical Magnesium GmbH
  • MetaMag Medical GmbH
  • nanoMAG GmbH
  • Orthos Mg GmbH
  • RegenMag Medical Solutions AG
  • Resomet GmbH
  • Shanghai Rebone Regenerative Medicine Technology Co., Ltd.
  • Syntellix AG
  • U&i Corporation
Product Code: MRR-7B550E008DEA

The Magnesium Alloy for Orthopedic Implants Market was valued at USD 234.15 million in 2025 and is projected to grow to USD 252.94 million in 2026, with a CAGR of 8.27%, reaching USD 408.56 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 234.15 million
Estimated Year [2026] USD 252.94 million
Forecast Year [2032] USD 408.56 million
CAGR (%) 8.27%

An informed overview of how advances in alloy chemistry, surface engineering, and clinical evidence are reshaping the viability of magnesium implants for modern orthopedic care

Magnesium alloys are emerging as a compelling material class for orthopedic implants, driven by their favorable mechanical properties, biodegradability, and compatibility with bone healing physiology. Over recent years, advances in alloy chemistry and surface engineering have improved corrosion control, enabling designers to exploit the unique combination of strength and gradual resorption that aligns with the biological timeline for bone remodeling. This alignment reduces the requirement for secondary removal surgeries in select indications and opens opportunities for novel treatment paradigms where temporary structural support suffices.

Clinically, the material's elastic modulus closer to that of cortical bone and its intrinsic ability to encourage osteogenesis through controlled ion release differentiate magnesium alloys from traditional permanent metals. Concurrently, manufacturers are refining processing routes-from extrusion and forging to additive manufacturing-and surface modification techniques, such as micro-arc oxidation and polymeric coatings, to tailor degradation rates and biological responses. Regulatory bodies have responded by clarifying pathways for bioresorbable metals, which in turn influences study design, clinical evidence generation, and post-market surveillance strategies.

As a result, stakeholders across clinical, industrial, and regulatory domains are actively reassessing product portfolios, R&D priorities, and commercialization roadmaps. Emerging clinical evidence and material science convergence suggest magnesium alloys will increasingly play a strategic role in trauma fixation, spinal applications, and craniomaxillofacial reconstruction, particularly where temporary mechanical support and minimized long-term hardware burden are clinical priorities. Consequently, multidisciplinary collaboration between surgeons, metallurgists, and regulatory specialists is crucial to translate laboratory promise into safe, effective, and commercially viable medical devices.

How converging demands from clinicians, regulators, and healthcare systems are accelerating materials innovation and clinical adoption of magnesium-based orthopedic devices

The orthopedics landscape is undergoing transformative shifts as materials innovation, clinical priorities, and health system economics converge. A notable shift is the increasing clinical emphasis on reducing long-term implant burden; surgeons and patients are seeking solutions that provide sufficient mechanical support during healing and then safely resorb, thereby eliminating the need for hardware removal procedures. This clinical imperative has propelled magnesium alloy research from experimental stages toward device prototypes and early clinical adoption, with continual improvements in corrosion control mitigating historical concerns about rapid degradation.

Meanwhile, surgical practice patterns are evolving with greater adoption of minimally invasive techniques and implant designs optimized for percutaneous delivery. These procedural shifts demand implants with predictable mechanical behavior and surface profiles compatible with soft tissue preservation. Moreover, supply chain resilience and cost pressures have encouraged device developers to streamline material sourcing and processing while maintaining rigorous quality and traceability standards.

Regulatory and reimbursement environments are also adapting; regulators are offering clearer guidance on preclinical and clinical evidence needs for resorbable metals, which in turn influences study design and time-to-market planning. Finally, patient expectations and market access strategies are shaping design priorities: implants must demonstrate not only safety and efficacy but also tangible benefits in patient recovery, reduced secondary procedures, and overall cost-effectiveness. Collectively, these forces are driving a step-change in how companies prioritize magnesium alloys within their innovation pipelines and commercial strategies.

Assessment of how recent tariff dynamics are reshaping supply chain strategies, vertical integration, and procurement decisions across the magnesium implant value chain

Recent tariff developments in the United States have introduced new variables into the supply chain calculus for manufacturers and distributors of magnesium alloy implants. Tariff adjustments influence cost structures across imported raw materials, semi-finished components, and finished devices, which in turn affects sourcing strategies and manufacturing footprints. Many suppliers are responding by evaluating alternative procurement routes, increasing domestic processing capabilities where feasible, and negotiating longer-term contracts to hedge against volatility.

For original equipment manufacturers and component suppliers, tariffs have sharpened the focus on vertical integration and regional diversification. Some companies are investing in localized alloy production and value-added processing to preserve margins and maintain price stability for customers. At the same time, distributors and implant manufacturers are reassessing international partnerships to balance compliance complexity with the need for quality-assured supply lines. These shifts are prompting greater transparency in cost build-ups and influencing pricing negotiations with hospital purchasing groups and healthcare systems.

Crucially, tariffs also affect R&D timelines when specialized feedstock or surface-treatment inputs are sourced internationally; extended lead times and increased costs can slow prototype iterations and clinical validation cycles. In response, stakeholders are prioritizing supply chain risk assessments, scenario planning, and alternative material qualification pathways to minimize disruption. Going forward, strategic supply chain planning and contractual agility will be essential to sustain innovation momentum while managing the commercial implications of tariff-driven cost shifts.

Comprehensive segmentation-driven insights that align implant form factors, clinical applications, distribution pathways, and material grades with commercialization imperatives

A nuanced understanding of product and clinical segmentation is essential to prioritize development and go-to-market efforts for magnesium alloy implants. Implant types include pins, plates, rods and nails, and screws, with plates further differentiated into compression plates, locking plates, and reconstruction plates, rods and nails encompassing intramedullary nails and locking rods, and screws categorized as cancellous screws, cortical screws, and self-tapping screws. Each implant form factor imposes distinct mechanical and degradation performance requirements, influencing alloy selection, heat treatment protocols, and surface finishing approaches.

Application areas span craniomaxillofacial, dental, spinal, sports medicine, and trauma, where spinal use is subdivided into minimally invasive and open surgery approaches and trauma indications include extremities trauma and pelvic trauma. These clinical contexts dictate design constraints such as load-bearing duration, geometry complexity, and biocompatibility thresholds, and they shape clinical trial endpoints and surgeon adoption curves. End users encompass ambulatory surgical centers, hospitals, and specialty clinics, each with different procurement cycles, purchasing power, and clinical workflows that affect adoption timing and required value propositions.

Distribution channels range from direct sales and distributors to e-commerce platforms, and each channel requires distinct commercial models, regulatory compliance touchpoints, and customer engagement strategies. Material grade selection-AZ31, Mg-Ca, Mg-Zn, and WE43-further refines product positioning by aligning corrosion behavior, mechanical performance, and regulatory familiarity with specific clinical use-cases. Together, these segmentation layers form a roadmap for targeted clinical evidence generation, manufacturing prioritization, and tailored commercialization approaches to accelerate clinician acceptance and patient benefit.

How regional regulatory diversity, clinician adoption patterns, and manufacturing capabilities influence commercialization strategies across major global regions

Regional dynamics shape regulatory expectations, clinical adoption patterns, and supply chain strategies for magnesium alloy implants. In the Americas, clinicians and hospital systems are increasingly receptive to innovations that reduce long-term procedural burden, but they require robust clinical evidence and clear regulatory documentation. This region also features concentrated purchasing groups and integrated health systems that can accelerate adoption for products demonstrating clear clinical and economic advantages.

In Europe, Middle East & Africa, regulatory frameworks emphasize rigorous safety evaluation coupled with regional variations in clinical practice and reimbursement structures. Market access strategies here must account for a mosaic of national health authorities and diverse procurement mechanisms. Early clinical adopters in this region can leverage center-of-excellence models to generate real-world evidence that supports broader uptake.

Asia-Pacific presents a heterogeneous landscape with rapid clinical uptake in select markets, strong metal manufacturing capability, and cost-sensitive procurement environments. Localized production and partnerships with regional manufacturers can reduce lead times and improve price competitiveness. Across all regions, harmonizing regulatory submissions and designing post-market surveillance plans that satisfy multiple jurisdictions will be critical to maintaining compliance and demonstrating long-term safety and performance.

Strategic competitive overview highlighting how integrated alloy development, manufacturing excellence, and clinical partnerships are defining market leaders and niche specialists

Competitive dynamics in the magnesium implant space reflect a mix of established orthopedic device companies expanding into bioresorbable metals and specialized material and component developers focusing on alloy innovation and surface treatment technologies. Key players are differentiating through integrated capabilities that combine alloy development, precision manufacturing, and clinical partnerships to accelerate evidence generation. Some firms emphasize proprietary surface coatings and corrosion-control technologies to achieve clinically predictable degradation profiles, while others invest in process control and certification to support scalable production.

Strategic collaboration between device OEMs and material science laboratories has become a common approach to de-risk product development and expedite the translation from bench to bedside. Partnerships with clinical centers for early feasibility studies and investigator-initiated trials are shaping surgeon confidence and informing iterative design improvements. Additionally, suppliers of medical-grade magnesium feedstock and specialized finishing services are building capability portfolios to support device manufacturers' time-to-market objectives.

As evidence accumulates, commercialization strategies are likely to bifurcate: companies with end-to-end capabilities will push toward integrated product offerings with strong clinical support, while niche specialists may capture value by licensing technologies or supplying high-performance alloys and coatings to larger device manufacturers. For purchasers and strategic partners, evaluating a company's depth across alloy metallurgical expertise, quality systems, and clinical evidence generation provides a meaningful signal of long-term viability.

Actionable strategic priorities for manufacturers to align clinical evidence, supply chain resilience, and targeted commercialization efforts for magnesium implants

Industry leaders should adopt a multi-pronged strategy to convert material promise into clinical and commercial success. First, prioritize targeted clinical studies that align implant design, material grade selection, and surgical technique to real-world endpoints valued by surgeons and payers; pragmatic trials and registries that capture functional outcomes and reoperation rates will be particularly persuasive. Second, invest in supply chain resilience by diversifying suppliers of critical feedstock, qualifying regional manufacturing partners, and implementing contractual safeguards that mitigate tariff and logistics exposure.

Third, accelerate regulatory readiness by engaging early with authorities to define acceptable preclinical models and post-market surveillance obligations; clear regulatory strategies reduce uncertainty and expedite market entry. Fourth, develop surgeon-facing education programs and collaborative initiatives with key opinion leaders to demonstrate handling, fixation techniques, and patient selection criteria that optimize clinical outcomes. Fifth, segment go-to-market efforts by matching distribution channels with end-user needs-direct sales models may work well for complex spinal systems, while broader trauma solutions might benefit from distributor networks or digital commerce pathways.

Finally, pursue materials and surface-engineering innovations that balance predictable degradation with mechanical reliability, and consider strategic partnerships or licensing to fill capability gaps. By aligning clinical evidence, manufacturing certainty, and targeted commercialization tactics, companies can materially improve clinician adoption and create defensible positions in a rapidly evolving landscape.

Detailed explanation of research methods that combine clinician interviews, material science literature, regulatory guidance, and supply chain analysis to produce a validated assessment

The research behind this analysis synthesized multiple inputs to construct a balanced, evidence-driven perspective on magnesium alloys in orthopedic implants. Primary research included structured interviews with clinicians across trauma, spinal, and craniomaxillofacial specialties; conversations with materials scientists, regulatory consultants, and device manufacturers; and direct engagements with supply chain and distribution stakeholders to understand procurement dynamics. These qualitative inputs were triangulated with publicly available scientific literature, regulatory guidance documents, and clinical study reports to validate material performance claims and clinical endpoints.

Secondary research focused on technical publications detailing alloy behavior, corrosion mitigation strategies, and biocompatibility data, as well as white papers and consensus statements from professional societies that inform clinical practice. The methodological approach emphasized cross-validation between clinical practice insights and material science findings to ensure recommendations are actionable and relevant to both product development and commercialization leaders.

Analytical rigor was maintained through iterative review cycles with subject-matter experts and by documenting assumptions, data sources, and limitations. Where evidence gaps exist-particularly in long-term comparative outcomes and large-scale post-market surveillance-recommendations advocate pragmatic study designs and real-world evidence collection strategies. The combined methodological approach yields a pragmatic, clinically oriented, and commercially relevant assessment suitable for executive decision-making.

Concise synthesis of material advances, clinical alignment, and commercialization imperatives that define the path to responsible adoption of magnesium-based orthopedic implants

In summary, magnesium alloys represent a strategically important material class for orthopedic applications where temporary mechanical support and biologically favorable resorption align with clinical objectives. Advances in alloy formulations, surface treatments, and manufacturing techniques have addressed many historical limitations, enabling more predictable degradation profiles and improved mechanical reliability. Concurrently, evolving clinical practice and regulatory clarity are creating pathways for responsible adoption, provided that developers invest in evidence generation and supply chain robustness.

The intersection of clinical need, materials innovation, and commercial pragmatism creates clear opportunities for organizations prepared to align R&D investments with targeted evidence strategies and distribution models. By focusing on surgeon engagement, rigorous preclinical and clinical validation, and resilient sourcing strategies, stakeholders can accelerate translation while mitigating risk. Ultimately, the successful commercialization of magnesium-based orthopedic implants will depend on multidisciplinary collaboration and disciplined execution across material science, clinical research, manufacturing, and commercial operations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Magnesium Alloy for Orthopedic Implants Market, by Implant Type

  • 8.1. Pins
  • 8.2. Plates
    • 8.2.1. Compression Plates
    • 8.2.2. Locking Plates
    • 8.2.3. Reconstruction Plates
  • 8.3. Rods & Nails
    • 8.3.1. Intramedullary Nails
    • 8.3.2. Locking Rods
  • 8.4. Screws
    • 8.4.1. Cancellous Screws
    • 8.4.2. Cortical Screws
    • 8.4.3. Self-Tapping Screws

9. Magnesium Alloy for Orthopedic Implants Market, by Material Grade

  • 9.1. AZ31
  • 9.2. Mg-Ca
  • 9.3. Mg-Zn
  • 9.4. WE43

10. Magnesium Alloy for Orthopedic Implants Market, by Application

  • 10.1. Craniomaxillofacial
  • 10.2. Dental
  • 10.3. Spinal
    • 10.3.1. Minimally Invasive
    • 10.3.2. Open Surgery
  • 10.4. Sports Medicine
  • 10.5. Trauma
    • 10.5.1. Extremities Trauma
    • 10.5.2. Pelvic Trauma

11. Magnesium Alloy for Orthopedic Implants Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Magnesium Alloy for Orthopedic Implants Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Magnesium Alloy for Orthopedic Implants Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Magnesium Alloy for Orthopedic Implants Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Magnesium Alloy for Orthopedic Implants Market

16. China Magnesium Alloy for Orthopedic Implants Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Alloy OrthoTech Co., Ltd.
  • 17.6. Bioretec Oy
  • 17.7. Biotronik SE & Co. KG
  • 17.8. Bone Solutions Ltd.
  • 17.9. Dongguan Eontec Co., Ltd.
  • 17.10. Magmaris Ltd.
  • 17.11. Magnesis Biomedical GmbH
  • 17.12. Magnesium Bioabsorbables Pvt. Ltd.
  • 17.13. Magnesium Development Company Ltd.
  • 17.14. Magnesium Innovations Inc.
  • 17.15. MedAlloy Technologies Inc.
  • 17.16. Medical Magnesium GmbH
  • 17.17. MetaMag Medical GmbH
  • 17.18. nanoMAG GmbH
  • 17.19. Orthos Mg GmbH
  • 17.20. RegenMag Medical Solutions AG
  • 17.21. Resomet GmbH
  • 17.22. Shanghai Rebone Regenerative Medicine Technology Co., Ltd.
  • 17.23. Syntellix AG
  • 17.24. U&i Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COMPRESSION PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COMPRESSION PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COMPRESSION PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RECONSTRUCTION PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RECONSTRUCTION PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RECONSTRUCTION PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING RODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING RODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING RODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANCELLOUS SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANCELLOUS SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANCELLOUS SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CORTICAL SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CORTICAL SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CORTICAL SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SELF-TAPPING SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SELF-TAPPING SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SELF-TAPPING SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY AZ31, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY AZ31, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY AZ31, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MG-CA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MG-CA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MG-CA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MG-ZN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MG-ZN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MG-ZN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY WE43, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY WE43, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY WE43, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPORTS MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPORTS MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPORTS MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTREMITIES TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTREMITIES TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTREMITIES TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PELVIC TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PELVIC TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PELVIC TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 190. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 192. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 195. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 196. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 220. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 222. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 225. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 226. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 230. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 231. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 233. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 235. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 236. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)